{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T20:49:37Z","timestamp":1760820577856,"version":"3.40.4"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1097\/ftd.0000000000000017","type":"journal-article","created":{"date-parts":[[2013,12,23]],"date-time":"2013-12-23T19:17:24Z","timestamp":1387826244000},"page":"295-301","source":"Crossref","is-referenced-by-count":6,"title":["Preliminary Assessment of Zolpidem Pharmacokinetics in Pediatric Burn Patients"],"prefix":"10.1097","volume":"36","author":[{"given":"Chris","family":"Stockmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine M. T.","family":"Sherwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Whitney","family":"Buterbaugh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael G.","family":"Spigarelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele M.","family":"Gottschlich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Healy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Kagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-4-20210129","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2165\/00003495-200059040-00014","article-title":"Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia.","volume":"59","author":"Holm","year":"2000","journal-title":"Drugs"},{"key":"R2-4-20210129","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/sleep\/18.4.246","article-title":"Zolpidem in the treatment of transient insomnia: a double-blind, randomized comparison with placebo.","volume":"18","author":"Roth","year":"1995","journal-title":"Sleep"},{"key":"R3-4-20210129","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1177\/030006059202000208","article-title":". The safety and efficacy of zolpidem in insomniac patients: a long-term open study in general practice.","volume":"20","author":"Maarek","year":"1992","journal-title":"J Int Med Res"},{"key":"R4-4-20210129","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00004850-199807000-00002","article-title":"Safety and tolerance of zolpidem in the treatment of disturbed sleep: a post-marketing surveillance of 16944 cases.","volume":"13","author":"Hajak","year":"1998","journal-title":"Int Clin Psychopharmacol"},{"key":"R5-4-20210129","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/S0140-6736(04)16360-5","article-title":"Support of the metabolic response to burn injury.","volume":"363","author":"Herndon","year":"2004","journal-title":"Lancet"},{"key":"R6-4-20210129","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0039-6109(16)41685-3","article-title":"Metabolic changes in burned patients.","volume":"58","author":"Wilmore","year":"1978","journal-title":"Surg Clin North Am"},{"key":"R7-4-20210129","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0304-3959(01)00282-2","article-title":". Quality of sleep and its daily relationship to pain intensity in hospitalized adult burn patients.","volume":"92","author":"Raymond","year":"2001","journal-title":"Pain"},{"key":"R8-4-20210129","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/01.ajp.0000129757.31856.f7","article-title":". How pain and analgesics disturb sleep.","volume":"21","author":"Onen","year":"2005","journal-title":"Clin J Pain"},{"key":"R10-4-20210129","first-page":"45","article-title":". Factors altering the sleep of burned children.","volume":"24","author":"Rose","year":"2001","journal-title":"Sleep"},{"key":"R11-4-20210129","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/01.BCR.0000124793.99886.6A","article-title":"Treating sleep problems in patients with burn injuries: practical considerations.","volume":"25","author":"Jaffe","year":"2004","journal-title":"J Burn Care Rehabil"},{"key":"R12-4-20210129","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/BCR.0b013e31815f384e","article-title":". A randomized, controlled prospective trial of zolpidem and haloperidol for use as sleeping agents in pediatric burn patients.","volume":"29","author":"Armour","year":"2008","journal-title":"J Burn Care Res"},{"key":"R13-4-20210129","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2165\/00003088-199529010-00003","article-title":"Clinical pharmacokinetics in patients with burns.","volume":"29","author":"Jaehde","year":"1995","journal-title":"Clin Pharmacokinet"},{"key":"R14-4-20210129","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2165\/00003088-199018020-00003","article-title":"Pathophysiology and pharmacokinetics following burn injury.","volume":"18","author":"Bonate","year":"1990","journal-title":"Clin Pharmacokinet"},{"key":"R15-4-20210129","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0731-7085(99)00311-8","article-title":"Validation of a method for the determination of zolpidem in human plasma using LC with fluorescence detection.","volume":"22","author":"Ring","year":"2000","journal-title":"J Pharm Biomed Anal"},{"key":"R16-4-20210129","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.csda.2004.07.002","article-title":"Maximum likelihood estimation in nonlinear mixed effects models.","volume":"49","author":"Kuhn","year":"2005","journal-title":"Comput Stat Data Anal"},{"key":"R17-4-20210129","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10928-010-9175-z","article-title":". The use of the SAEM algorithm in MONOLIX software for estimation of population pharmacokinetic-pharmacodynamic-viral dynamics parameters of maraviroc in asymptomatic HIV subjects.","volume":"38","author":"Chan","year":"2011","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"R18-4-20210129","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/BF02353864","article-title":"Comparison of the akaike information criterion, the schwarz criterion and the F test as guides to model selection.","volume":"22","author":"Ludden","year":"1994","journal-title":"J Pharmacokinet Biopharm"},{"key":"R19-4-20210129","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF01062336","article-title":"Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics.","volume":"10","author":"Boxenbaum","year":"1982","journal-title":"J Pharmacokinet Biopharm"},{"key":"R20-4-20210129","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s40262-013-0033-1","article-title":". Population pharmacokinetics of tranexamic acid in paediatric patients undergoing craniosynostosis surgery.","volume":"52","author":"Goobie","year":"2013","journal-title":"Clin Pharmacokinet"},{"key":"R21-4-20210129","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.cmpb.2007.12.002","article-title":"Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: the npde add-on package for R.","volume":"90","author":"Comets","year":"2008","journal-title":"Comput Methods Programs Biomed"},{"key":"R22-4-20210129","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0022-3565(24)39253-5","article-title":". Comparative kinetics and response to the benzodiazepine agonists triazolam and zolpidem: evaluation of sex-dependent differences.","volume":"293","author":"Greenblatt","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"R23-4-20210129","doi-asserted-by":"crossref","first-page":"49","DOI":"10.5664\/jcsm.26297","article-title":". The use of pharmacotherapy in the treatment of pediatric insomnia in primary care: rational approaches. A consensus meeting summary.","volume":"1","author":"Owens","year":"2005","journal-title":"J Clin Sleep Med"},{"key":"R24-4-20210129","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/sj.clpt.6100380","article-title":". Potential pharmacokinetic basis for zolpidem dosing in children with sleep difficulties.","volume":"83","author":"Blumer","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"R26-4-20210129","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2165\/00003088-200847100-00002","article-title":". Influence of burns on pharmacokinetics and pharmacodynamics of drugs used in the care of burn patients.","volume":"47","author":"Blanchet","year":"2008","journal-title":"Clin Pharmacokinet"},{"key":"R27-4-20210129","first-page":"1277","article-title":". Low-dose sublingual zolpidem tartrate is associated with dose-related improvement in sleep onset and duration in insomnia characterized by middle-of-the-night (MOTN) awakenings.","volume":"31","author":"Roth","year":"2008","journal-title":"Sleep"},{"key":"R29-4-20210129","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1001\/jama.2013.323","article-title":"FDA warning: driving may be impaired the morning following sleeping pill use.","volume":"309","author":"Kuehn","year":"2013","journal-title":"JAMA"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000000017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T08:53:00Z","timestamp":1746089580000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007691-201406000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000000017","relation":{},"ISSN":["0163-4356"],"issn-type":[{"type":"print","value":"0163-4356"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}